Key Considerations for Pharmacists Administering RSV Vaccines

The panelists provide guidance on how pharmacists should advise patients on recognizing RSV symptoms that require urgent medical attention.

EP: 1.Preventing RSV in Adults: Current Vaccination Options

EP: 2.Identifying Contraindications Before Administering RSV Vaccines

EP: 3.Strategies for Addressing Vaccine Hesitancy in RSV Patient Populations

EP: 4.Counseling Patients on RSV Vaccine Safety and Efficacy

EP: 5.Addressing Respiratory Vaccine Fatigue

EP: 6.Impact of Social Determinants of Health on Respiratory Syncytial Virus (RSV)

EP: 7.Raising RSV Awareness Among High-Risk Patient Populations

EP: 8.Challenges of Concurrent Administration: RSV and Other Vaccines

EP: 9.The Pharmacist's Role in Shared Decision-Making for RSV Vaccination

Now Viewing

EP: 10.Key Considerations for Pharmacists Administering RSV Vaccines

EP: 11.Unmet Needs in Prevention and Management of RSV

EP: 12.Empowering RSV Patients: Essential Vaccine Education Resources

EP: 13.Understanding RSV Infection Patterns and Seasonal Outbreaks

EP: 14.Closing Remarks on RSV Vaccinations

Related Videos

Related Content

Advertisement

May 13th 2025

Carefully Consider Optimal Timing of RSV Vaccination in Older Adults

Lisa Rosenberg, PharmD, BCGP

May 12th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor

May 1st 2025

Adult RSV-ARI Linked to Higher Death Risk and Health Care Costs

Kennedy Ferruggia, Assistant Editor

April 29th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor

April 17th 2025

ACIP Votes to Expand Lowering RSV Vaccine Recommendation Age to 50 for High-Risk Adults

Kennedy Ferruggia, Assistant Editor

April 11th 2025

Study Finds Reduction in RSV Hospitalizations Among Vaccinated Older Adults in England

Kennedy Ferruggia, Assistant Editor

Related Content

Advertisement

May 13th 2025

Carefully Consider Optimal Timing of RSV Vaccination in Older Adults

Lisa Rosenberg, PharmD, BCGP

May 12th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor

May 1st 2025

Adult RSV-ARI Linked to Higher Death Risk and Health Care Costs

Kennedy Ferruggia, Assistant Editor

April 29th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor

April 17th 2025

ACIP Votes to Expand Lowering RSV Vaccine Recommendation Age to 50 for High-Risk Adults

Kennedy Ferruggia, Assistant Editor

April 11th 2025

Study Finds Reduction in RSV Hospitalizations Among Vaccinated Older Adults in England

Kennedy Ferruggia, Assistant Editor